Inj, ocriplasmin, 0.125 mg
This code is not in the latest file (4Q26). It was last listed in 2Q21.
Payment limit per 0.125 MG, by effective quarter, 1Q21 to 2Q21. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J7316
No NDCs mapped to this code in the 4Q26 crosswalk.
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 2Q21 | $1,046.927 | $0.00 | 0.125 MG | Inj, ocriplasmin, 0.125 mg | v1, posted March 1, 2022 |
| 1Q21 | $1,046.927 | – | 0.125 MG | Inj, ocriplasmin, 0.125 mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021